An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278–285. doi:10.1002/ijc.2024415197783
   PubMed Web of Science ®Google Scholar
• Martins AE, Lucena-Silva N, Garcia RG, et al. Prevalence of human papillomavirus infection, distribution of viral types and risk factors in cervical samples from human immunodeficiency virus-positive women attending three human immunodeficiency virus-acquired immune deficiency syndrome reference centres in northeastern Brazil. Mem Inst Oswaldo Cruz. 2014;109(6):738–747.25317701
   PubMed Web of Science ®Google Scholar
• Wright TC, Stoler MH, Behrens CM, et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189–197. doi:10.1016/j.ygyno.2014.11.07625579108
   PubMed Web of Science ®Google Scholar
• Zhang S, McNamara M, Batur P. Cervical cancer screening: what‘s new? Updates for the busy clinician. Am J Med. 2018;131:702 e1–e5. doi:10.1016/j.amjmed.2017.12.017
   PubMed Web of Science ®Google Scholar
• Guo M, Lin CY, Gong Y, et al. Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results. Mod Pathol. 2008;21(8):1037–1043. doi:10.1038/modpathol.2008.9318500260
   PubMed Web of Science ®Google Scholar
• Tota JE, Bentley J, Blake J, et al. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: acting on evidence to change the current paradigm. Prev Med. 2017;98:5–14. doi:10.1016/j.ypmed.2016.11.02928279264
   PubMed Web of Science ®Google Scholar
• Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131(17):2201–2221. doi:10.1042/CS2016078628798073
   PubMed Web of Science ®Google Scholar
• Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018;26(2):158–168. doi:10.1016/j.tim.2017.07.00728823569
   PubMed Web of Science ®Google Scholar
• Varnai AD, Bollmann M, Bankfalvi A, et al. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications. Oncol Rep. 2008;19(2):457–465.18202795
   PubMed Web of Science ®Google Scholar
• Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol. 2011;120(1):89–93. doi:10.1016/j.ygyno.2010.09.01320950847
   PubMed Web of Science ®Google Scholar
• Zhang CQ, Huang CG, Zheng X, Pan D. Prevalence of human papillomavirus among Wenzhou women diagnosed with cervical intraepithelial neoplasia and cervical cancer. Infect Agent Cancer. 2018;13:37. doi:10.1186/s13027-018-0211-830505342
   PubMed Web of Science ®Google Scholar
• Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer. 2017;123(12):2219–2229. doi:10.1002/cncr.3058828346680
   PubMed Web of Science ®Google Scholar
• Coutlée F, Ratnam S, Ramanakumar AV, et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011;83(6):1034–1041. doi:10.1002/jmv.2208121503917
   PubMed Web of Science ®Google Scholar
• Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117:S5–10. doi:10.1016/j.ygyno.2010.01.02420304221
   PubMed Web of Science ®Google Scholar
• Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses. 2015;7(7):3863–3890. doi:10.3390/v707280226193301
   PubMed Web of Science ®Google Scholar
• Chen HC, Schiffman M, Lin CY, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst. 2011;103(18):1387–1396. doi:10.1093/jnci/djr28321900119
   PubMedGoogle Scholar
• Benevolo M, Vocaturo A, Caraceni D, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol. 2011;49(7):2643–2650. doi:10.1128/JCM.02570-1021525231
   PubMed Web of Science ®Google Scholar
• Duvlis S, Popovska-Jankovic K, Arsova ZS, et al. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women. J Med Virol. 2015;87(9):1578–1586. doi:10.1002/jmv.2419925880030
   PubMed Web of Science ®Google Scholar
• Cuschieri K, Cubie H, Graham C, et al. Clinical performance of RNA and DNA based HPV testing in a colposcopy setting: influence of assay target, cut off and age. J Clin Virol. 2014;59(2):104–108. doi:10.1016/j.jcv.2013.12.00124380720
   PubMed Web of Science ®Google Scholar
• Munkhdelger J, Choi Y, Lee D, et al. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Diagn Microbiol Infect Dis. 2014;79(4):422–427. doi:10.1016/j.diagmicrobio.2014.04.00424856365
   PubMed Web of Science ®Google Scholar
• Wallace NA, Galloway DA. Novel functions of the human papillomavirus E6 oncoproteins. Annu Rev Virol. 2015;2(1):403–423. doi:10.1146/annurev-virology-100114-05502126958922
   PubMedGoogle Scholar
• Roman A, Munger K. The papillomavirus E7 proteins. Virology. 2013;445(1–2):138–168. doi:10.1016/j.virol.2013.04.01323731972
   PubMed Web of Science ®Google Scholar
• Fontecha N, Basaras M, Hernáez S, et al. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. BMC Cancer. 2016;16(1):852.27816058
   PubMedGoogle Scholar
• Bzhalava D1, Guan P, Franceschi S, Dillner J, Clifford G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013;445(1–2):224–231. doi:10.1016/j.virol.2013.07.01523928291
   PubMed Web of Science ®Google Scholar